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Abstract
Next-generation sequencing technologies have revolutionized the identification
of disease-causing genes, accelerating the discovery of new mutations and
new candidate genes for thyroid diseases. To face this flow of novel genetic
information, it is important to have suitable animal models to study the
mechanisms regulating thyroid development and thyroid hormone availability
and activity. Zebrafish ( ), with its rapid external embryonicDanio rerio
development, has been extensively used in developmental biology. To date,
almost all of the components of the zebrafish thyroid axis have been
characterized and are structurally and functionally comparable with those of
higher vertebrates. The availability of transgenic fluorescent zebrafish lines
allows the real-time analysis of thyroid organogenesis and its alterations.
Transient morpholino-knockdown is a solution to silence the expression of a
gene of interest and promptly obtain insights on its contribution during the
development of the zebrafish thyroid axis. The recently available tools for
targeted stable gene knockout have further increased the value of zebrafish to
the study of thyroid disease. All of the reported zebrafish models can also be
used to screen small compounds and to test new drugs and may allow the
establishment of experimental proof of concept to plan subsequent clinical
trials.
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Introduction
Thyroid hormones (THs) play an essential role in vertebrate 
development and metabolism regulation. The thyroid gland is 
then principally controlled by the negative feedback exerted by 
circulating THs at the pituitary and hypothalamic level in order 
to gauge the secretion of TSH, the thyroid-stimulating hormone1. 
Thyroid function is further controlled at the tissue level by the 
peripheral gatekeepers of TH action, including the TH transport-
ers (e.g. MCT8) and the iodothyronine deiodinases. In most 
species, deiodinases type 1 and 2 enzymatically convert the 
pro-hormone thyroxine (T4) to the bioactive hormone trio- 
iodothyronine (T3) and deiodinases type 1 and 3 can instead 
inactivate T3 to di-iodothyronine, T2. Ultimately, binding of 
T3 to its base on nuclear receptors (TRs) regulates the expres-
sion of specific genes by activating or suppressing transcription 
rates. Thus, proper TH action requires 1) the development of a 
functional hypothalamic-pituitary-thyroid axis, 2) transport of 
THs across the cell membrane, 3) an appropriate TH intracellular 
metabolism, and 4) T3 binding to the nuclear TRs and activation 
of gene expression2. Thus, mutations on genes involved in all of 
these steps result in a wide range of TH defects (e.g. congeni-
tal hypothyroidism [CH], TH cell membrane transporter defect 
[THCMTD], or resistance to TH [RTH])2–4. Although the patho-
logical mechanisms can be very different, all of them result in 
aberrant expression of the T3 target genes required for the devel-
opment and function of organs and tissues. As a result, TH 
defects not only delay normal development but also lead, if 
untreated, to irreversible lifelong defects in the nervous system. 
Cutting-edge technologies, such as those based on next-generation 
sequencing, are continuously providing unprecedented insights 
into the mechanisms involved in several forms of congenital 
thyroid defects. The challenge that we now have to face is identify-
ing powerful systems for the functional validation of new hypoth-
eses or putative pathogenic variants in candidate genes. In vitro 
assays or mouse models certainly continue to play a vital role 
in such functional validation strategies, but in recent years the 
zebrafish has also become a relevant model to test novel hypoth-
eses or understand the role of candidate genes for several human 
diseases. Accordingly, this model has been more and more 
frequently used in studies on thyroid pathophysiology because of 
its versatility, limited costs, and the relatively shortened time to 
obtain significant results when compared with other animal 
models as well as the broad conservation of the molecular 
mechanisms involved in thyroid development and function and 
TH action5,6.
Here, we review the current knowledge on the development of 
the thyroid system in zebrafish, how recent clinical observations 
on this model shaped our understanding of thyroid diseases, and 
how these insights might be translated into therapeutic approaches 
(Figure 1).
Zebrafish to study thyroid development
In humans, CH represents the most common congenital endo-
crine disorder, affecting 3–6 out of 10,000 neonates. It is classi-
cally described to be a sporadic disease, but recent data support a 
possible oligogenic origin of CH, whose pathogenesis could thus 
frequently depend upon the combination of hypomorphic alleles 
of developmental or functional genes3. However, the molecular 
mechanisms underlying CH, and thyroid dysgenesis in particu-
lar, remain largely unexplained. This is, in part, due to our still-
limited understanding on how the function of intrinsic factors 
Figure 1. Schematic illustration of the most recent findings concerning thyroid development and thyroid hormone (TH) action that 
have been obtained using zebrafish as a model system. CNS, central nervous system; EDC, endocrine disruptor chemical; KD, knockdown; 
KO, knockout; mct8, monocarboxylate transporter 8; RTH, resistance to thyroid hormone.
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(e.g. thyroid-specific transcription factors) and extrinsic signal-
ing cues (e.g. morphogens and growth factors) are integrated to 
regulate thyroid organogenesis.
The study of thyroid anatomy and its alterations after genetic 
manipulation using the zebrafish model offers several advan-
tages that could overcome some of the technical limitations that 
are associated with using mammalian models. In contrast to intrau-
terine development in mammals, zebrafish embryos and larvae 
develop externally and are optically transparent, making them 
accessible to experimental manipulation and real-time obser-
vations throughout their entire embryonic development. These 
properties coupled with the availability of transgenic embryos 
expressing fluorescent reporter proteins in specific cell types 
allow the visualization and the study of organ development, includ-
ing that of the thyroid gland. Opitz and colleagues have devel-
oped a panel of transgenic zebrafish lines in which the promoter 
of thyroglobulin (tg) was used to drive the expression of differ-
ent fluorescent proteins that allow time-lapse live imaging and 
real-time visualization of the dynamic changes in size, shape, and 
location of the developing zebrafish thyroid5,7.
Moreover, the availability of tools for the knockdown (mor-
pholinos [MOs]) or knockout (e.g. the CRISPR/Cas9 system) of 
a gene of interest facilitates the analysis of the impact of a certain 
mutation during thyroid development. In modeling diseases using 
zebrafish, choosing between MOs and the CRISPR/Cas9 sys-
tem depends on the particular situation. MOs are an established 
tool that has been utilized for the functional knockdown of many 
genes, while the CRIPSR/Cas9 system is an integrated toolbox 
that facilitates functional gene perturbations, such as loss and 
gain of function8. MOs are designed to investigate phenotypes 
in the early developmental stages of the fish; however, the nor-
mal point at which to observe phenotypes in a CRISPR-Cas9- 
mediated transgenic fish is following the generation of F2, 
which normally takes over six months. Interestingly, a discrep-
ancy was reported in the phenotypes between the previously 
described MO-treated fish and recently generated transgenic 
fish9. The use of MOs is discouraged in some cases, consider-
ing the unprecedented phenotypes and possible off-target effects. 
However, in other cases, MOs work extremely well and effi-
ciently mimic mutant phenotypes observed either in humans or in 
experimental models. Surprisingly, complete gene knockout was 
reported to be associated with the absence of the expected 
phenotype because of the unpredictable induction of a genetic 
compensation by other related genes able to offset the pheno-
type seen with MO10. Interestingly, the compensation does not 
happen with MO. Thus, both MO- and CRISPR/Cas9-based 
approaches can be valuable and their application depends upon 
the aims of the study.
Despite the anatomic differences (Figure 2), the molecular 
mechanisms of thyroid organogenesis appear to be well con-
served between zebrafish and mammalian models. For a detailed 
description of zebrafish thyroid organogenesis and the under-
lying molecular events, the readers are referred to an excellent 
Figure 2. Schematic illustration of zebrafish thyroid development (modified from 7). The thyroid primordium rises from the pharyngeal 
endoderm around 24 hours post-fertilization (hpf) and expresses the early thyroid genes nkx2.4, pax2a, pax8, hhex, and foxe1. The 
differentiation of thyroid precursors continues up to 48hpf, at which they begin to express the late thyroid genes tg and slc5a5. The 
development of the zebrafish thyroid gland is complete at 72hpf. From this time, the thyroid follicles proliferate and localize along the 
dorsal aorta and start to produce T4. Intrinsic and extrinsic factors (Jag1-Notch, bone morphogenetic protein [BMP], and fibroblast 
growth factor [FGF] signaling) are also reported to play a pivotal role during thyroid organogenesis. For a detailed description of the 
molecular mechanisms underlying zebrafish thyroid morphogenesis, we refer the reader to the review by Fagman and Nilsson11.
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review11. During the first three days of development, the zebrafish 
thyroid gland is not yet formed and the embryos are depend-
ent on the maternal THs stored in the yolk sac5,12. As develop-
ment progresses, the thyroid is formed from a midline anlage in 
the pharyngeal floor consisting of foregut endoderm cells that are 
committed to a thyroid fate. These thyroid progenitors give rise 
specifically to the follicular cells that proliferate to form mature 
TH-producing follicles. As described in mice, knockdown experi-
ments in zebrafish demonstrated that the transcription factors 
nkx2.1, pax2a, and hhex are necessary for the specification and 
differentiation of thyroid primordium11. The only exception is 
foxe1, which regulates thyroid primordium migration in higher 
vertebrates and mimics the picture of thyroid ectopia in nearly 
50% of mutant mice11. In zebrafish, foxe1 is expressed in thy-
roid progenitors, but no effects on thyroid morphogenesis were 
observed in foxe1 MO-injected zebrafish embryos13. These 
authors argued that the zebrafish thyroid develops very early 
during development and foxe1’s role might be redundant in this 
context; it is thus possible that the role of FOXE1 in mammalian 
thyroid development may have been acquired during evolution.
Once the thyroid gland is developed, it starts to produce THs, 
whose levels are finely regulated by the hypothalamic– 
pituitary–thyroid axis. Tonyushkina et al. developed a trans-
genic zebrafish that expresses GFP under the control of the tshba 
promoter (orthologous to the human TSH). They observed that 
the TH-driven negative feedback regulation of tshba transcrip-
tion appears by four days post fertilization, the time in which the 
thyroid gland is already active14. Interestingly, the authors showed 
that early exposure to elevated or low TH levels leads to thy-
rotrope cell death or hyperplasia, respectively14,15. These data 
demonstrate that transient TH changes profoundly impact 
the thyrotrope population during a critical period of pituitary 
development and may have long-term implications for the TSH 
set point later in life.
We have recently used the zebrafish model to analyze the func-
tional consequences of several human JAG1 variants. JAG1 is a 
ligand of the Notch receptors that has been found to be 
mutated in patients with CH16. We observed that knockdown 
of the zebrafish orthologues jag1 and ja1b results in thyroid 
hypoplasia and TSH elevation that can be normalized by the 
human wild-type JAG1. Confirming the results observed in vitro, 
co-injection with the human JAG1 variants in zebrafish mor-
phants failed to revert, at various degrees, the associated defects16, 
emphasizing the usefulness of the zebrafish model to study the 
contribution of JAG1/Notch to thyroid function.
Pappalardo and colleagues used the zebrafish to study the role 
of Taz, a signal-responsive transcriptional coregulator, in thyroid 
formation17. The wwtr1 (encoding for the zebrafish Taz) 
transcript is expressed in the thyroid primordium and pharyn-
geal tissue of developing zebrafish, but its knockdown has only 
little effects on the expression of thyroid transcription factors 
and differentially alters the expression of thyroid differentiation 
genes. In later stages, Taz-depleted larvae exhibited a reduced 
number of thyroid follicle cells, indicating that the zebrafish 
Taz protein is required for normal thyroid morphogenesis17. 
These data point to considerable genetic heterogeneity in this 
disorder, although no genetic alteration has been described in the 
TAZ gene in patients with CH so far.
To study CH pathogenesis comprehensively, the influence of the 
surrounding tissues during thyroid development should be taken 
into account. Opitz et al. recently described the role of netrin-1 
in the pathogenesis of CH. Netrin-1 mutations have been detected 
in patients with co-occurring thyroid dysgenesis and congenital 
heart disease18. In zebrafish, ntn1a is expressed in the pharyn-
geal arch and mesenchyme but not in the thyroid tissue. Ntn1a- 
deficient embryos displayed defective development of the aortic 
arch artery and abnormal thyroid morphogenesis. The thyroid 
phenotype is a result of the lack of proper guidance exerted by 
the dysplastic vasculature18. Considering the close spatiotemporal 
relationship between thyroid and outflow tract development and 
the strong influence of the signals emanating from the cardiac 
mesoderm on thyroid development, such as BMPs and FGFs, 
netrin-1 is a strong candidate for having a direct role during 
thyroid development.
Zebrafish to study thyroid cancer
A couple of recent manuscripts described the use of zebrafish 
to study the biology of thyroid cancer. Our group reported that 
patient-derived xenografts from papillary thyroid cancer or nor-
mal tissue stimulate the migration and the growth of sprouting 
vessels towards the implant in zebrafish embryos. This in vivo 
model could thus be considered as a valuable platform to test 
the effects of anticancer drugs19. More recently, a novel model 
of thyroid carcinoma in zebrafish was reported20. Through the 
use of real-time in vivo imaging, the authors studied a zebrafish 
line expressing BRAFV600E in thyrocytes that developed 
invasive carcinoma occurring early in thyroid development and 
disrupting thyroid follicle structure. Interestingly, combinatorial 
treatment using BRAF and MEK inhibitors reversed the devel-
opmental effects induced by BRAFV600E and the authors 
identified a gene expression signature from zebrafish thyroid 
cancer. Gene expression studies identified TWIST2 as a crucial 
effector downstream of BRAF. The authors utilized CRISPR/
Cas9 to genetically inactivate a TWIST2 orthologue, suppress-
ing the effects of BRAFV600E and restoring thyroid morphology 
and hormone synthesis. This implies that TWIST2 expres-
sion is involved in an early stage of BRAFV600E-mediated 
transformation.
Zebrafish to study TH transport defects
Once produced and released into the blood, THs require 
transport across the plasma membrane to gain access to the intra-
cellular compartments. Monocarboxylate transporter 8 (MCT8) and 
10 (MCT10) and the organic anion transporter proteins (OATPs) 
are all members of the solute carrier superfamily and have been 
shown to transport THs21. In particular, MCT8 (also named 
SLC16A2) is necessary for the uptake of T3 in brain neurons, 
one of the most important cellular targets of T32. The biological 
importance of MCT8 is proven by the manifestations of the 
Allan–Herndon–Dudley syndrome (AHDS) that carry dysfunc-
tional mutations in the MCT8 gene. AHDS is an X-linked disease 
characterized by severe psychomotor retardation, muscle 
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hypotonia and hypoplasia, ataxia, and impaired cognitive func-
tion. The underlying pathological mechanism is still elusive, and 
no cure for this condition is known2. Mct8-knockout mice exhibit 
the same alterations in TH homeostasis as AHDS cases but with-
out any brain dysfunction or locomotor disability22. To improve 
understanding of AHDS, the zebrafish model has been exten-
sively used in the last few years. Vatine and colleagues iso-
lated the zebrafish mct8 promoter, generating a transgenic line 
that confirms that mct8 is primarily expressed in neurons, glial 
cells, and the vascular system, as in mammals23. The first mct8 
model was generated 1 year later by the same group using 
MO-based gene knockdown24. The mct8 morphants exhibited 
impaired locomotor behavior and defective development of the 
cerebellum and mid-hindbrain boundary and apoptotic clusters 
in the zebrafish brain. Consistent with findings in patients, the 
authors also showed that the expression of zebrafish orthologues 
of the mammalian TSH, TH transporters, and deiodinases was 
affected in mct8 morphants24. More recently, they developed 
a mct8 zebrafish mutant model (mct8–/–) using the zinc finger 
nuclease (ZFN)-mediated targeted gene editing system25. Simi-
lar to patients, mct8–/– larvae displayed reduced locomotor activ-
ity and deficiency in behavioral performance, likely due to an 
altered development of sensory and motor neurons25. Furthermore, 
mct8–/– mutants demonstrated neurological abnormalities and 
hypomyelination in the CNS. Pharmacological analysis showed 
that TH analogues and clemastine can partially rescue the 
hypomyelination in the CNS of mct8−/− larvae26. Moreover, T3 
treatment rescued hypomyelination in mct8−/− embryos before 
the maturation of the blood-brain barrier (BBB) but did not 
affect hypomyelination in later stages26.
Taken together, these results emphasize the suitability of 
zebrafish as an animal model to study thyroid pathophysiology 
and AHDS by uncovering the effectiveness of early pharmacologi-
cal treatments and BBB-targeted gene therapy that can enhance 
myelination in AHDS and possibly in other TH-dependent brain 
disorders27.
Zebrafish to study TH metabolism defects
Different tissues and cell types require TH at varying levels, and 
this is also the case throughout each of the developmental stages. 
Membrane transporters regulate TH entry into cells so as to deliver 
the proper intracellular hormone supply, and this is further fine-
tuned by intracellular metabolism, which is controlled by three 
selenoprotein iodothyronine deiodinases (Ds). The only inher-
itable TH metabolism defect (THMD) known so far is the one 
resulting from recessive mutations in the selenocysteine insertion 
sequence-binding protein 2 (SECISBP2 [in short, SBP2]) gene, 
which influences selenoprotein synthesis, including the sele-
noenzymes deiodinases2. The study of SBP2 defects in zebrafish 
is currently in progress in our lab (data not shown). There have 
been no reports as yet of humans with mutations in the deiodinase 
genes. Nevertheless, studies in animal models anticipated that 
mutations in other genes causing defective TH metabolism might 
have variable phenotypes.
Zebrafish studies indicated that D2 regulates the tempo of early 
embryonic development. D2-knockdown embryos, obtained by 
MO microinjection, resulted in a developmental delay, whereas 
D1 knockdown has minor effects28. Houbrechts et al. have 
generated two different dio2 (dio2–/–) mutant zebrafish lines 
using ZFNs. Both mutants displayed a complete lack of D2 
activity and a large diminution of T3 concentration in tissues29. 
These mutants also exhibited early developmental perturbations, 
impaired locomotor activity, and long-term effects on growth and 
fertility29. The D3 (encoded by two orthologues, dio3a and dio3b) 
was first implicated in the process of fin regeneration. Heijlen 
and colleagues recently showed that MO-mediated knockdown 
of either dio3a or dio3b results in partial loss of inner-ring 
deiodinase activity in the whole embryo, indicating that both para-
logues may encode active enzymes30. Moreover, the MO knock-
down of both dio3 transcripts induced a delay in development 
and reduced locomotor activity, suggesting that D3 knockdown 
can affect muscle and retinal development and function31,32. The 
same group also analyzed the transcriptome of the double 
knockdown D1/D2 (D1D2MO) and knockdown of D3 (D3MO) 
in zebrafish larvae. Both conditions resulted in a differential 
expression of genes involved in energy metabolism and muscle 
development31. The up-regulation of transcripts encoding the 
ATP proteins seems to reflect a compensatory response to a 
decreased metabolic rate, a condition linked to hypothyroidism in 
D1D2MOs. Increased metabolic rate and stimulation of gluco-
neogenesis associated with delayed hatching and an increase 
in heart rate and carbohydrate content were reported in D3MO31.
These findings provide new insight on the role of deiodinases 
during development, highlighting the importance of a correct TH 
balance during vertebrate development.
Zebrafish to study TR defects
In zebrafish, TH action is mediated by different receptors (TRα1 
and TRα2, TRβ1 and TRβ2) encoded by two genes (THRA and 
THRB), with differing tissue distribution33.
Until a few years ago, the term RTH was applied to the pheno-
type associated with dominant- negative (DN) mutations in the 
THRB gene. With the identification of DN mutations in the THRA 
gene, which presents with an extremely different phenotype, the 
syndromes are now identified as RTHβ and RTHα33. The basic 
features of RTHβ include elevated serum free THs with non- 
suppressed TSH and goiter along with thyrotoxic and hypothy-
roid manifestations that are variable and largely unexplained 
(e.g. anxiety, tachycardia, failure to thrive, impaired hearing and 
color vision, attention-deficit hyperactivity disorder, and low bone 
density) in different tissues2. We observed that the zebrafish thrb 
transcript is mainly expressed in the eye, pituitary, and otic vesicle 
of embryos34. The generation of a DN model by MO microinjec-
tion demonstrated that TRβ isoforms are necessary for the proper 
development of sensory organs. Moreover, the TRβ morphants 
displayed the typical biochemical signature of RTHβ with a 
reduced sensitivity of the pituitary to L-T4 treatment34. Suzuki and 
colleagues generated a TRβ2 fluorescent transgenic line and 
demonstrated that L-cone differentiation in the zebrafish retina 
requires TRβ2 activity35. MO TRβ2 knockdown leads to L-cone 
reduction and a concomitant increase of UV cones. Conversely, 
ectopic expression of TRβ2 after cone differentiation produces 
cones with mixed opsin expression35.
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Since 2012, different heterozygous mutations in the THRA gene 
have been described in patients with RTHα4. The associated 
symptoms are reminiscent of untreated CH (growth retarda-
tion, psycho-neuromotor disorders, delayed bone development, 
and bradycardia) but with a raised T3/T4 ratio and normal TSH 
levels. All variations fall in the ligand-binding domain (LBD), 
and mutant receptors present reduced T3 binding or defective 
interaction with corepressors or coactivators and variably 
affect the activity of the co-expressed normal receptors in a DN 
manner. As a consequence, RTHα patients present variable 
responses to TH treatment4. During zebrafish embryonic devel-
opment, TRα transcript is mainly localized in the CNS, heart, 
gastrointestinal tract, and pronephric ducts. Moreover, 
embryos harboring DN mutations in the LBD of zebrafish TRα 
isoforms recapitulated most of the key clinical and biochemi-
cal manifestations (e.g. growth and brain defects, delayed 
cartilage development, defective heart function, and high T3/
T4 ratio) described in RTHα patients34. We observed increased 
pituitary dio2 and reduced dio3a and dio3b that can explain the 
peculiar biochemical features found in patients with RTHα. 
We also reported that zebrafish and human TRs were function-
ally interchangeable and that high T3 doses partially reverted the 
DN action of mutant hTRα in morphants34.
More recently, we established a simplified RTHα in vivo model 
by the direct microinjection of human THRA transcripts into 
zebrafish eggs36. The embryos injected with human variants 
(hTRα-injected embryos) undergo profound morphologi-
cal, neurological, cardiovascular, hematological, skeletal, and 
biochemical alterations reminiscent of RTHα in humans. Consist-
ently with in vitro results, an efficient rescue of the disease phe-
notypes was always seen upon the addition of a high T3 concen-
tration in the harvesting water only in embryos injected with the 
missense variants, which are partially resistant to T3 in contrast 
with the complete refractoriness of the truncated mutations36. 
Therefore, the whole of these findings support the view that the 
observed fish phenotypes are specifically caused by the DN 
activity exerted by hTRα mutants on zTRs and that zebrafish 
may become a useful ‘biotool’ to test new therapeutic approaches 
to cure RTHα. Indeed, treatment with a TH analogue selec-
tively targeting mutant TRα may be preferable to thyroxine 
treatment, which can have untoward effects on TRβ-mediated 
pathways.
While this review was under revision, the Stainier lab described 
an important role for TH action during pancreatic islet matura-
tion using a novel TH-responsive reporter line37. They found that 
both α and β cells become targets of endogenous TH signaling 
during the larval-to-juvenile transition. Therefore, it appears 
that endogenous THs, beyond their requirement for the embryo- 
to-larval transition described by Liu and Chan several years 
ago38, are also required during the larval transition for the 
functional maturation of α and β cells in order to maintain glucose 
homeostasis.
Zebrafish to study the toxic effects on thyroid 
function
A number of studies have been finally reported in recent years 
on the use of zebrafish to study the effects of endocrine disrup-
tor chemicals (EDCs). Several evaluated the effects of bisphe-
nol AF or S (BPAF or BPS) exposure39–41. Treatment with such 
pollutants induced variable changes in TH concentrations as 
well as in TH metabolism and action. These data provide inter-
esting insights on the toxicity of these compounds but are often 
difficult to interpret, as opposite effects (decrease or increase of 
thyroxine concentrations) are seen in different studies39,40 and 
significant effects with contrasting or divergent results on gene 
expression are seen in both thyroid and hypothalamic-pituitary 
tissues.
Conclusions
In this review, we attempted to summarize the most recent 
findings concerning thyroid development and TH action that have 
been obtained in zebrafish during the last four years (Figure 1). 
All of these data highlight the great potential of this model to 
investigate thyroid diseases. Zebrafish embryos are particularly 
useful thanks to their small size, rapid development, and optical 
transparency. Given the conservation of the molecular mecha-
nisms regulating thyroid development and TH action in zebrafish 
and mammals, the availability of fluorescent reporters and several 
techniques for genetic manipulation make zebrafish a powerful 
model to investigate the mechanisms underlying human 
developmental or neoplastic diseases. The generation of specific 
genetic models can efficiently harness the advantages of 
zebrafish embryos for a phenotypic characterization of novel 
candidate genes. In addition, these models will also be suitable 
for drug screening and will greatly accelerate the development of 
new treatment protocols.
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